ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1021

Organ Damage in Systemic Lupus Erythematosus Is Attributable More to Comorbidity (Hypertension) and Less to Socioeconomic Status

Romy Kallas1, Jessica Li2, Daniel Goldman3 and Michelle Petri3, 1Johns Hopkins Medical Institution, Baltimore, MD, 2Johns Hopkins University, Baltimore, MD, 3Johns Hopkins University School of Medicine, Timonium, MD

Meeting: ACR Convergence 2020

Keywords: Comorbidity, Damage Index, risk assessment, socioeconomic factors, Systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Epidemiology & Public Health Poster III: Inflammatory Rheumatic Disease

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Multiple variables are known to contribute to development of organ damage in SLE patients, including prednisone use and ethnicity. The aim of this study was to evaluate the attributable risk due to comorbidities (hypertension, obesity, smoking), and socioeconomic factors on the total SLICC/ACR Damage Index (DI) and its sub-items in a large longitudinal prospective SLE cohort.

Methods: We analyzed data from a longitudinal cohort of 2,436 SLE patients who met the revised ACR or SLICC classification criteria (43% African-American, 57% Caucasian and 92% female). The SLICC/ACR DI was calculated based on organ damage that occurred after the diagnosis with SLE until the last visit. The outcome variable was the total damage score and that of each organ system at the last available cohort visit. We calculated the population attributable risk (PAR) for the total and each organ damage. Person month files since SLE diagnosis were created. At each month, variables were created to identify if patients had damage accrual. We analyzed the data using pooled logistic regression where the outcome was binary for each organ (accrual of damage). To account for the fact that some patients could contribute multiple damage events in the analysis, the GEE approach was used in fitting the model. Each model was adjusted for sex and age at the person month. Regression coefficients from the model were then used to calculate PAR.

Results: The mean total SLICC/ACR DI was 1.9 (SD=2.3). Hypertension was the strongest contributor to damage accrual, after adjusting for age and sex (Table 1 and 2). Hypertension was responsible for 30% of total damage: 70% of renal damage and 40% of cardiovascular damage was attributed to hypertension. The importance of hypertension was true regardless of ethnicity. Obesity was a strong contributor to neuro-psychiatric (23%) and renal (15.4) damage in Caucasians. It played a less important role in African-American patients, contributing only 3% and 0.8% to neuro-psychiatric and renal damage, respectively. Obesity was protective against skin damage in both African-Americans and Caucasians. Smoking contributed mostly to cardiovascular (13%) and skin (32%) damage. (Table 1). Only about 10% of any organ damage was accounted for by socioeconomic status. The 3 socioeconomic measures, education, low income, and insurance, contributed equally to total damage in patients with SLE. Socioeconomic status played a greater role in skin (28.3%) and peripheral vascular damage (21.5%), compared to damage in the other organ systems (Table 2).

Conclusion: Of the three comorbidities, hypertension had the highest PAR for total, renal and cardiovascular damage, regardless of ethnicity.  Obesity had a protective effect for skin damage.  The three measures of socioeconomic status were less important than hypertension.  Low income appeared to attribute more PAR than education or type of insurance.  The Eight Americas Study found that ethnicity, rather than socioeconomic status, explained the ethnic differences in mortality.  Our study suggests that ethnicity and hypertension are the most important contributors to organ damage (the strongest predictor of mortality).


Disclosure: R. Kallas, None; J. Li, None; D. Goldman, None; M. Petri, Astrazeneca, 2, 5, Exagen, 2, 5, GlaxoSmithKline (GSK), 2, 5, Eli Lilly and Company, 2, 5, AbbVie Inc., 5, Aleon Pharma International, Inc, 5, Amgen, 5, Annenberg Center for Health Sciences,, 5, Blackrock Pharma, 5, Bristol Myers Squibb, 5, Decision Resources, 5, Glenmark Pharmaceuticals, 5, INOVA, 5, IQVIA, 5, Janssen Pharmaceutical, 5, Merck EMD Serono, 5, Novartis, 5, Sanofi Japan, 5, Thermofisher, 5, UCB, 5.

To cite this abstract in AMA style:

Kallas R, Li J, Goldman D, Petri M. Organ Damage in Systemic Lupus Erythematosus Is Attributable More to Comorbidity (Hypertension) and Less to Socioeconomic Status [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/organ-damage-in-systemic-lupus-erythematosus-is-attributable-more-to-comorbidity-hypertension-and-less-to-socioeconomic-status/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/organ-damage-in-systemic-lupus-erythematosus-is-attributable-more-to-comorbidity-hypertension-and-less-to-socioeconomic-status/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology